4/A

PRIMARY DOCUMENT

Company: Inhibitor Therapeutics, Inc.
Filed: March 23, 2004
Period of Report: November 12, 2003
Accession Number: 0001234066-04-000009

View Document ↗ View on SEC.gov ↗